恶性胶质瘤患者的临终关怀利用情况
基于SEER-Medicare关联数据库,纳入2002年1月1日至2011年12月31日诊断且2012年12月31日前死亡的12437例成人恶性胶质瘤患者,其中7849例(63%)死亡前接受临终关怀。多因素分析显示年龄较大、女性、较高教育水平、白人种族和较低家庭收入中位数预测临终关怀入组;入组者中位临终关怀停留时间为21天(四分位距8-45天)。
要点
- 12437例恶性胶质瘤患者中7849例(63%)死亡前入组临终关怀。
- 入组临终关怀者中6996例(89%)停留超过3天,6047例(77%)超过7天。
- 年龄较大、女性、城市居住是多因素分析中较长停留时间(至少3天或7天)的预测因素。
核心结论
- 恶性胶质瘤患者的临终关怀利用存在重要差异,差异体现在种族、性别、年龄、教育水平和城乡居住地方面。
- 需要进一步研究这些阻碍更早和更广泛利用临终关怀的障碍。
研究设计与样本
- 使用监测、流行病学和最终结果(SEER)-Medicare关联数据库,识别2002年1月1日至2011年12月31日诊断且2012年12月31日前死亡的成人恶性胶质瘤患者。
- 提取社会人口学和临床数据,用单因素逻辑回归分析比较临终关怀接受者与非接受者的特征。
- 用多因素逻辑回归分析检验死亡前超过3天或超过7天入组临终关怀的预测因素。
主要发现
- 共识别12437例合格患者(46%为女性),其中7849例(63%)死亡前入组临终关怀。
- 多因素回归分析中,年龄较大、女性、较高教育水平、白人种族和较低家庭收入中位数预测临终关怀入组。
- 入组临终关怀者中,6996例(89%)入组超过3天,6047例(77%)入组超过7天。
- 多因素分析中,年龄较大、女性和城市居住是较长停留时间(至少3天或7天)的预测因素。
- 所有入组患者的中位临终关怀停留时间为21天(四分位距8-45天)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite recommendations from professional organizations supporting early hospice enrollment for patients with cancer, little research exists regarding end-of-life (EOL) practices for patients with malignant glioma (MG). We evaluated rates and correlates of hospice enrollment and hospice length of stay (LOS) among patients with MG. METHODS: Using the Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked database, we identified adult patients who were diagnosed with MG from January 1, 2002 to December 31, 2011 and who died before December 31, 2012. We extracted sociodemographic and clinical data and used univariate logistic regression analyses to compare characteristics of hospice recipients versus nonrecipients. We performed multivariable logistic regression analyses to examine predictors of hospice enrollment >3 or >7 days prior to death. RESULTS: We identified 12437 eligible patients (46% female), of whom 7849 (63%) were enrolled in hospice before death. On multivariable regression analysis, older age, female sex, higher level of education, white race, and lower median household income predicted hospice enrollment. Of those enrolled in hospice, 6996 (89%) were enrolled for >3 days, and 6047 (77%) were enrolled for >7 days. Older age, female sex, and urban residence were predictors of longer LOS (3- or 7-day minimum) on multivariable analysis. Median LOS on hospice for all enrolled patients was 21 days (interquartile range, 8-45 days). CONCLUSIONS: We identified important disparities in hospice utilization among patients with MG, with differences by race, sex, age, level of education, and rural versus urban residence. Further investigation of these barriers to earlier and more widespread hospice utilization is needed.
引用
- Forst D, Adams E, Nipp R, et al. Hospice utilization in patients with malignant gliomas. Neuro Oncol. 2018. PMID: 29045712. doi:10.1093/neuonc/nox196
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。